A carregar...
Publicação
Reply to Wilson: The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 477.01 KB | Adobe PDF |
Orientador(es)
Resumo(s)
No abstract available
Descrição
The 4-Month Isoniazid, Rifapentine, Moxifloxacin, and Pyrazinamide Treatment Regimen for Drug-Susceptible Pulmonary Tuberculosis: A Word of Caution. Am J Respir Crit Care Med. 2025 Aug;211(8):1525.doi: 10.1164/rccm.202501-0222LE.
Letter
Letter
Palavras-chave
Tuberculosis Drug-susceptible TB treatment Infecções Respiratórias
Contexto Educativo
Citação
Am J Respir Crit Care Med. 2025 Aug;211(8):1526. doi: 10.1164/rccm.202503-0679LE
Editora
American Thoracic Society